Detailed price information for Vera Therapeutics Inc Cl A (VERA-Q) from The Globe and Mail including charting and trades.
Travere Therapeutics, Inc. a présenté de nouvelles données sur des biomarqueurs issues de l’étude de phase 3 PROTECT, apportant des éléments tendant à démontrer que FILSPARI® ...
MedPage Today on MSN
Atacicpet, Sibeprenlimab Halt Decline in Kidney Function in IgA Nephropathy
Final data from ORIGIN and VISIONARY trials pave way for full FDA approvals ...
Travere Therapeutics reported durable biomarker data for FILSPARI in IgA nephropathy, but shares fell 4.5% as markets focus ...
Hamilton U.S. T-Bill YIELD MAXIMIZER ETF USD Unhedged UnitsHBIL.U:TOR Hamilton U.S. T-Bill YIELD MAXIMIZER ETF USD Unhedged UnitsHBIL.U:TOR HAMILTON CHAMPIONS™ Canadian Financials Index ETFHFN:TOR ...
Travere Therapeutics, Inc. (Nasdaq: TVTX) today presented new biomarker data from the Phase 3 PROTECT Study providing ...
Travere Therapeutics presented Phase 3 PROTECT biomarker findings suggesting FILSPARI may modify underlying disease ...
트라베레 테라퓨틱스(Travere Therapeutics)는 필스파리(FILSPARI)가 IgA 신증 성인 환자의 기저 질환 병태생리를 변화시킬 수 있음을 시사하는 3상 PROTECT 바이오마커 결과를 발표했습니다.
Rødspættefileter, fiskefrikadeller og torskeloins er genkendelige størrelser for de fleste danskere. Man kender dem fra ...
Travere (TVTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...
With a late Thursday nod from the FDA to reduce protein levels in the urine of patients with primary immunoglobulin A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results